Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/35522
Type
ArticleCopyright
Open access
Collections
- IFF - Artigos de Periódicos [1300]
- INI - Artigos de Periódicos [3646]
Metadata
Show full item record
DELAYED CHILDHOOD NEURODEVELOPMENT AND NEUROSENSORY ALTERATIONS IN THE SECOND YEAR OF LIFE IN A PROSPECTIVE COHORT OF ZIKV-EXPOSED CHILDREN
Salles, Tania Regina Dias Saad. Fundação Oswaldo Cruz. Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.
1 David Geffen UCLA School of Medicine, CA, Los Angeles, USA. 2 Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. 3 Biomedical Research Institute of Southern California, CA, Oceanside, USA. 4Faculty of Medicine, University of São Paulo, São Paulo, Brazil. 5 Medical University of Graz, Graz, Austria. 6University Medical Center, Göttingen, Germany. 7 UCSF School of Medicine, CA, San Francisco, USA. 8State Key Laboratory of Molecular Developmental Biology, CAS Center for Excellence in Brain Science and Intelligence Technology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. 9Parkinson’s Disease Center, Beijing Institute for Brain Disorders, Beijing, China.
Author
Nielsen-Saines, Karin
Brasil, Patrícia
Kerin, Tara
Vasconcelos, Zilton Farias Meira de
Gabaglia, Claudia Raja
Damasceno, Luana
Pone, Marcos
Carvalho, Liege M. Abreu de
Pone, Sheila M.
Zin, Andrea A.
Tsui, Irena
Salles, Tania Regina Dias Saad
Cunha, Denise Cotrim da
Costa, Roozemerie Pereira
Malacarne, Jociele
Reis, Ana Beatriz
Hasue, Renata Hydee
Aizawa, Carolina Y. P.
Genovesi, Fernanda F.
Einspieler, Christa
Marschik, Peter B.
Pereira, José Paulo
Gaw, Stephanie L.
Adachi, Kristina
Cherry, James D.
Xu, Zhiheng
Cheng, Genhong
Moreira, Maria Elisabeth
Brasil, Patrícia
Kerin, Tara
Vasconcelos, Zilton Farias Meira de
Gabaglia, Claudia Raja
Damasceno, Luana
Pone, Marcos
Carvalho, Liege M. Abreu de
Pone, Sheila M.
Zin, Andrea A.
Tsui, Irena
Salles, Tania Regina Dias Saad
Cunha, Denise Cotrim da
Costa, Roozemerie Pereira
Malacarne, Jociele
Reis, Ana Beatriz
Hasue, Renata Hydee
Aizawa, Carolina Y. P.
Genovesi, Fernanda F.
Einspieler, Christa
Marschik, Peter B.
Pereira, José Paulo
Gaw, Stephanie L.
Adachi, Kristina
Cherry, James D.
Xu, Zhiheng
Cheng, Genhong
Moreira, Maria Elisabeth
Affilliation
Múltipla - Ver em Notas.
Abstract
We report neurodevelopmental outcomes in 216 infants followed since the time of PCR-confirmed maternal Zika virus (ZIKV) infection in pregnancy during the Rio de Janeiro epidemic of 2015-2016 (refs. 1,2). Neurodevelopment was assessed by Bayley Scales of Infant and Toddler Development, third edition (Bayley-III; cognitive, language and motor domains) in 146 children and through neurodevelopment questionnaires/neurological examinations in 70 remaining children. Complete eye exams (n = 137) and hearing assessments (n = 114) were also performed. Below-average neurodevelopment and/or abnormal eye or hearing assessments were noted in 31.5% of children between 7 and 32 months of age. Among children assessed by Bayley-III, 12% scored below -2 s.d. (score <70; a score of 100 ± 2 s.d. is the range) in at least one domain; and 28% scored between -1 and -2 s.d. in any domain (scores <85-70). Language function was most affected, with 35% of 146 children below average. Improved neurodevelopmental outcomes were noted in female children, term babies, children with normal eye exams and maternal infection later in pregnancy (P = 0.01). We noted resolution of microcephaly with normal neurodevelopment in two of eight children, development of secondary microcephaly in two other children and autism spectrum disorder in three previously healthy children in the second year of life.
Publisher
Nature Research
Citation
NIELSEN-SAINES, Karin et al. Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children. Nature Medicine, v. 25, p. 1213-1217, Aug. 2019.DOI
10.1038/s41591-019-0496-1ISSN
1078-8956Notes
Patrícia Brasil. Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.Salles, Tania Regina Dias Saad. Fundação Oswaldo Cruz. Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.
1 David Geffen UCLA School of Medicine, CA, Los Angeles, USA. 2 Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. 3 Biomedical Research Institute of Southern California, CA, Oceanside, USA. 4Faculty of Medicine, University of São Paulo, São Paulo, Brazil. 5 Medical University of Graz, Graz, Austria. 6University Medical Center, Göttingen, Germany. 7 UCSF School of Medicine, CA, San Francisco, USA. 8State Key Laboratory of Molecular Developmental Biology, CAS Center for Excellence in Brain Science and Intelligence Technology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. 9Parkinson’s Disease Center, Beijing Institute for Brain Disorders, Beijing, China.
Share